PMVP

PMV Pharmaceuticals, Inc. · Healthcare

Insiders sold $1.5M net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Oct 27, 2025

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.5M

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Latest filing

Oct 29, 2025

ORBIMED ADVISORS LLC

PMV Pharmaceuticals, Inc. (PMVP) has 2 SEC Form 4 filings (2 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 29, 2025.

Inside the rolling window, 1 insider at PMV Pharmaceuticals, Inc. reported no open-market purchases and 1 open-market sale totaling $1.5M. Insiders have net sold $1.5M over the trailing 6 months. The most recent open-market filing is a sale of 1,000,000 shares by 10% Owner ORBIMED ADVISORS LLC, dated Oct 23, 2025, worth $1.5M.

  • Industry:Biotechnology
  • CEO:David H. Mack
  • Employees:54
  • HQ:Princeton, NJ, US
  • IPO:2020-09-25
Source
Sale$1.5MOct 27SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does PMVP have?

PMV Pharmaceuticals, Inc. (PMVP) has 2 SEC Form 4 filings (2 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 29, 2025.

When was the most recent SEC Form 4 filing for PMVP?

The most recent Form 4 filing for PMVP on Tracefour is dated Oct 29, 2025.

What is the net insider flow at PMVP over the last 6 months?

Over the trailing 180 days, insiders at PMVP have net sold $1.5M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at PMVP in the current window?

Inside the rolling window, insiders at PMVP bought $0 and sold $1.5M based on SEC Form 4 filings.

Can I get alerts for PMVP insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PMV Pharmaceuticals, Inc. (PMVP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

PMV Pharmaceuticals, Inc. is in the Healthcare sector.